In June I will be looking for some of the top recent research advances in bipolar disorder.
Although less common than unipolar depression, bipolar disorder is a serious disorder with high rates of disability and hospitalization.
I will try to cover the spectrum of important areas in bipolar disorder during the month including: epidemiology, risk factors, biomarkers, genetics, brain imaging, neuropsychology, psychopharmacology and psychological interventions.
Here is a starting group of important studies. Some will be covered in more detail in a future post. Click on the study title to be taken to the full abstract and the free full-text manuscript.
Suicidal behavior in bipolar disorder with antidepressant use
This study examined participants in the Collaborative Depression Study, a naturalistic longitudinal study of bipolar I, bipolar II and unipolar depression. The study found a 54% reduction in suicidal behavior in bipolar I subjects receiving antidepressant therapy and a 35% reduction in bipolar II subjects receiving antidepressants. Of note, use of antidepressants in unipolar depression was not linked to change in suicidal behavior frequency.
Anti-inflammatory markers in bipolar disorder: Effects of celecoxib (Celebrex)
Mood disorders are commonly linked to elevated markers of inflammation including serum cytokines. In this study, subjects with bipolar disorder receiving electroconvulsive therapy were randomly assigned to the anti-inflammatory drug celecoxib versus placebo. Celecoxib treatment was linked to reduced levels of tumor necrosis factor-alpha but not to reduced levels of two interleukin levels and c reactive protein levels.
Biomarkers in bipolar disorder
This manuscript is a review of the literature in biomarker research for bipolar disorder. The authors found support for several brain structural markers including reduced gray matter volumes in the prefrontal cortex. Serum measures of neutrophic factors, oxidative stress and inflammation also hold promise as biomarkers in bipolar disorder.
Brain connectivity in bipolar disorder vs schizophrenia vs controls
A study of resting state connectivity using functional magnetic resonance imaging targeted a group of subjects with bipolar disorder, schizophrenia and healthy controls. The study found significant differences in connectivity between bipolar subjects and controls although these differences were less pronounced than the differences between a group of schizophrenics and controls.
Genome-wide association studies of schizophrenia, bipolar disorder and unipolar disorder
This study examined results from 60,000 subjects in the Psychiatric Genomics Consortium. The study found evidence for common pathways across the schizophrenia, bipolar and unipolar groups that involve neuronal, immune function and histone methylation.
Follow me on Twitter for updates in neuroscience research. @WRY999
Photo of orangutan is from the author's files.
No comments:
Post a Comment